Alexander Hamil

Alexander Hamil has worked in the field of science since 2008. Alexander began as an Undergraduate Researcher with Hubert Schorle at the University of Bonn, working on the project "Generation of Transgenic Mice Expressing AP-2 γ Transcription Factor." Alexander then moved to UC Irvine as a Research Specialist in the Laboratory of David M. Gardiner and Susan V. Bryant. In 2010, they joined the University of California San Diego as a Graduate Student Researcher with Steven F. Dowdy, working on the thesis project "BioReversible Prodrug RNAi Therapeutics to Treat Cancer." Alexander then became a Postdoctoral Scholar with Steven F. Dowdy, working on the project "Antibody-RNA Conjugates (ARC) to Treat Cancer." In 2019, they began working as a Senior Scientist at Wugen.

Alexander Hamil attended UC San Diego from 2010 to 2016, where they earned a Doctor of Philosophy (Ph.D.) in Biomedical Sciences. Prior to that, they attended UC Irvine from 2005 to 2009, where they earned a Bachelor of Science (B.S.) in Genetics.